Connection

Michael Hallek to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Antineoplastic Agents, Immunological.
Michael Hallek
Connection Strength
0.025
Antineoplastic Agents, Immunological
  1. Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood. 2017 09 21; 130(12):1477-1480.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.